LightNews LightNews
lizts.bsky.social
@lizts.bsky.social
300 followers 1K following 2 posts
Posts Replies Media Videos
Reposted
jennifilm.nz
Here are the headline paragraphs. The Ministry emphatically did not recommend this ban, and in fact repeatedly pointed out the significant level of harm it was likely to cause. The consultation found overwhelming support for continued access. The only people who thought different were cabinet.
Assessing Option Four against the criteria 147. Option Four, like the other regulatory options, offers less benefit under each criterion when compared to Option One. While it puts safety and caution first, based on a lack of evidence of safety or benefit, the approach is unlikely to be as effective as status quo because it removes the practitioner's ability to consider and respond in the best interests of the individual. This could be alleviated to some degree through patients attending the alternative services but may not resolve the medical issue that young people with gender incongruence/dysphoria are presenting for. Like Option 3b and 3c, people that desperately want to delay puberty while they consider their identity may try to purchase products online where there are safety issues with the quality. 152. Health equity issues would not improve, nor would trust and confidence in the health sector, given regulation of a particular medicine for a particular health problem would be regulated for the first time. Access to the alternative health services could help provide some trust and confidence because individuals would be cared for by specialists. However, without the availability of puberty blockers, this effect would likely be minor. The need to develop additional gender services may result in the reallocation of resources from other higher-priority areas of health. al), as described in the above table. Option 4 - Regulations to prohibit new prescribing while making youth gender services more accessible A prohibition on new prescribing would protect against potential harm. However, this option has a high risk of adverse health outcomes (similar to options 3b and 3c) due to possible negative impacts on mental health, despite medical and psychosocial support through the alternative services. The lack of access to puberty blockers would not treat the indication in many of the cases. What option is likely to best address the problem, meet the policy objectives, and deliver the highest net benefits? 153. The Ministry of Health considers Option One (Status Quo / Counterfactual: baseline of close Ministry monitoring and adjustment as needed) is the best fit for the policy objectives. 154. There is no evidence base to know the likely impact of other options, given they have not been previously tried in this type of context. Also, the steps already taken have not yet had time to be fully embedded and therefore time is needed to evaluate their impact fully.
December 18, 2025 at 7:53 AM
lizts.bsky.social
www.youtube.com/watch?v=ZpUY...
#BHN 2pm Livestream with Craig Renney for Budget headlines
YouTube video by DOC Studios
www.youtube.com
May 22, 2025 at 3:39 AM